Production (Stage)
Utah Medical Products, Inc.
UTMD
$53.76
$0.100.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.79% | -18.55% | 3.19% | -12.71% | -7.70% |
| Total Depreciation and Amortization | -1.23% | -1.35% | 6.78% | 1.46% | -34.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -202.26% | -- | 100.00% | 4.46% | 66.96% |
| Change in Net Operating Assets | 201.21% | -85.23% | 65.00% | -270.49% | 117.10% |
| Cash from Operations | 51.99% | -23.83% | 39.61% | -47.65% | -1.05% |
| Capital Expenditure | -1,944.44% | 89.89% | 19.09% | -400.00% | 75.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Investing | -1,944.44% | 89.89% | 22.61% | -2,400.00% | 105.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 206.25% | -- |
| Repurchase of Common Stock | 51.99% | -73.54% | 39.62% | -114.15% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.02% | 1.33% | 2.68% | 0.73% | -1.68% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.29% | -57.52% | 31.60% | -80.52% | -271.90% |
| Foreign Exchange rate Adjustments | 146.73% | -271.09% | 934.78% | 87.15% | -173.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.37% | -613.95% | 83.29% | -588.19% | -79.82% |